Supply of Transcatheter Aortic Valve Replacement (TAVR) Medical Devices

The Department of Veterans Affairs, through its Network Contract Office 23, has established a subcontract to procure FDA-cleared Transcatheter Aortic Valve Replacement (TAVR) medical devices for use in VA healthcare facilities. This agreement ensures the consistent supply of specialized cardiac devices to meet the clinical needs of veteran patients requiring minimally invasive aortic valve replacement. The contract covers not only the delivery of the devices but also includes comprehensive billing support and replacement services to maintain uninterrupted patient care and operational efficiency within VA medical centers. The procurement is classified under NAICS code 339113, indicating it pertains to medical equipment and supplies manufacturing, and the contract is structured to align with federal procurement standards for medical technology. The agreement is active as of July 10, 2026, and performance is expected to occur across VA facilities nationwide, though no specific location is designated. The contracting office is responsible for managing the relationship with vendors to ensure compliance with regulatory requirements and timely fulfillment of medical device orders.